125 related articles for article (PubMed ID: 35288524)
21. Invasive micropapillary carcinoma of the extrahepatic bile duct and its malignant potential.
Yoshizawa T; Toyoki Y; Hirai H; Haga T; Toba T; Sakuraba S; Okano K; Wu Y; Seino H; Morohashi S; Hakamada K; Kijima H
Oncol Rep; 2014 Oct; 32(4):1355-61. PubMed ID: 25109922
[TBL] [Abstract][Full Text] [Related]
22. Clinical and prognostic significances of nuclear and cytoplasmic KIT expressions in extrahepatic bile duct carcinomas.
Hong SM; Hwang I; Song DE; Choi J; Yu E
Mod Pathol; 2007 May; 20(5):562-9. PubMed ID: 17396144
[TBL] [Abstract][Full Text] [Related]
23. [Carcinomas of the distal bile duct].
Bahra M; Langrehr JM; Neuhaus P
Chirurg; 2006 Apr; 77(4):335-40. PubMed ID: 16523255
[TBL] [Abstract][Full Text] [Related]
24. Minimally invasive papillary carcinoma of the extrahepatic bile ducts.
Fatima S; Ahmad Z; Qureshi A; Minhas K; Pal I
J Coll Physicians Surg Pak; 2008 Oct; 18(10):649-51. PubMed ID: 18940127
[TBL] [Abstract][Full Text] [Related]
25. Expression of GalNAc-T3 and its relationships with clinicopathological factors in 61 extrahepatic bile duct carcinomas analyzed using stepwise sections - special reference to its association with lymph node metastases-.
Inoue T; Eguchi T; Oda Y; Nishiyama K; Fujii K; Izumi H; Kohno K; Yamaguchi K; Tanaka M; Tsuneyoshi M
Mod Pathol; 2007 Feb; 20(2):267-76. PubMed ID: 17361208
[TBL] [Abstract][Full Text] [Related]
26. Confinement to the intrapancreatic bile duct is independently associated with a better prognosis in extrahepatic cholangiocarcinoma.
Ahn KS; Kang KJ; Kang YN; Kim YH; Kim TS
BMC Gastroenterol; 2016 Feb; 16():21. PubMed ID: 26911927
[TBL] [Abstract][Full Text] [Related]
27. Benefits and limitations of middle bile duct segmental resection for extrahepatic cholangiocarcinoma.
Akita M; Ajiki T; Ueno K; Tsugawa D; Tanaka M; Kido M; Toyama H; Fukumoto T
Hepatobiliary Pancreat Dis Int; 2020 Apr; 19(2):147-152. PubMed ID: 32037277
[TBL] [Abstract][Full Text] [Related]
28. Prognostic Impact of CD163+ Macrophages in Tumor Stroma and CD8+ T-Cells in Cancer Cell Nests in Invasive Extrahepatic Bile Duct Cancer.
Miura T; Yoshizawa T; Hirai H; Seino H; Morohashi S; Wu Y; Wakiya T; Kimura N; Kudo D; Ishido K; Toyoki Y; Kijima H; Hakamada K
Anticancer Res; 2017 Jan; 37(1):183-190. PubMed ID: 28011489
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathological significance of olfactomedin-4 in extrahepatic bile duct carcinoma.
Jun SY; An S; Huh T; Chung JY; Hong SM
Pathol Res Pract; 2020 May; 216(5):152940. PubMed ID: 32276789
[TBL] [Abstract][Full Text] [Related]
30. EGFR, COX2, p-AKT expression and PIK3CA mutation in distal extrahepatic bile duct carcinoma.
Moon A; Chin S; Kim HK; Kwak JJ; Koh ES; Kim YW; Jang KT
Pathology; 2016 Jan; 48(1):35-40. PubMed ID: 27020207
[TBL] [Abstract][Full Text] [Related]
31. Left hemihepatectomy and caudate lobectomy and complete extrahepatic bile duct resection using transduodenal approach for hilar cholangiocarcinoma arsing from biliary papillomatosis.
Kim JK; Hwang HK; Park JS; Cho SI; Yoon DS; Chi HS
J Surg Oncol; 2008 Aug; 98(2):139-42. PubMed ID: 18521837
[TBL] [Abstract][Full Text] [Related]
32. When hepatic-side ductal margin is positive in N+ cases, additional resection of the bile duct is not necessary to render the negative hepatic-side ductal margin during surgery for extrahepatic distal bile duct carcinoma.
Iso Y; Kita J; Kato M; Shimoda M; Kubota K
Med Sci Monit; 2014 Mar; 20():471-5. PubMed ID: 24657986
[TBL] [Abstract][Full Text] [Related]
33. Surgical treatment and postoperative outcomes for middle and lower bile duct carcinoma in Japan--experience of a single institute.
Suzuki M; Unno M; Oikawa M; Endo K; Katayose Y; Matsuno S
Hepatogastroenterology; 2000; 47(33):650-7. PubMed ID: 10919005
[TBL] [Abstract][Full Text] [Related]
34. Intrahepatic, peri-hilar and distal cholangiocarcinoma: Three different locations of the same tumor or three different tumors?
Ercolani G; Dazzi A; Giovinazzo F; Ruzzenente A; Bassi C; Guglielmi A; Scarpa A; D'Errico A; Pinna AD
Eur J Surg Oncol; 2015 Sep; 41(9):1162-9. PubMed ID: 26095704
[TBL] [Abstract][Full Text] [Related]
35. Small-cell Neuroendocrine Carcinoma of the Extrahepatic Bile Duct: A Rare Case Report.
Han B; Seo YJ; Oh GH; You GR; Ma KY; Kim KH; Noh MG; Joo YE
Korean J Gastroenterol; 2023 Mar; 81(3):121-124. PubMed ID: 36960694
[TBL] [Abstract][Full Text] [Related]
36. Cystic duct remnant carcinoma with widespread invasion along the extrahepatic bile duct wall: dynamic CT findings.
Gabata T; Matsui O; Sanada J; Kadoya M; Ohmura K; Minato H
Abdom Imaging; 2003; 28(1):79-82. PubMed ID: 12483391
[TBL] [Abstract][Full Text] [Related]
37. Prognosis and treatment of bile duct carcinoma.
Chung C; Bautista N; O'Connell TX
Am Surg; 1998 Oct; 64(10):921-5. PubMed ID: 9764692
[TBL] [Abstract][Full Text] [Related]
38. Experimental study on pathogenesis and histomorphology of early carcinoma of the extrahepatic bile duct in the Syrian hamster.
Tajima Y; Tomioka T; Ikematsu Y; Yamanaka S; Kuroki T; Kitajima T; Fukuda K; Tsuneoka N; Kitazato A; Adachi T; Kanematsu T
J Exp Clin Cancer Res; 2005 Sep; 24(3):475-82. PubMed ID: 16270535
[TBL] [Abstract][Full Text] [Related]
39. The association between extrahepatic biliary carcinoma and the junction of the cystic duct and the biliary tree.
Ohtani T; Shirai Y; Tsukada K; Hatakeyama K; Muto T
Eur J Surg; 1994 Jan; 160(1):37-40. PubMed ID: 8186312
[TBL] [Abstract][Full Text] [Related]
40. Lymphatic spread differs according to tumor location in extrahepatic bile duct cancer.
Yoshida T; Matsumoto T; Sasaki A; Morii Y; Shibata K; Ishio T; Kitano S
Hepatogastroenterology; 2003; 50(49):17-20. PubMed ID: 12629981
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
